Point of Care Molecular Diagnostics Market Size Report, 2032

Point of Care Molecular Diagnostics Market - By Technology (PCR, In Situ Hybridization, Sequencing, Isothermal Amplification), By Application (Infectious Disease, Oncology, Hematology), By End-use (Hospitals, Clinics, Diagnostic Centers) & Forecast, 2023-2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Methodology

1.2&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.3&nbsp;&nbsp;&nbsp; Base estimates and calculations

1.3.1&nbsp;&nbsp;&nbsp; North America

1.3.2&nbsp;&nbsp;&nbsp; Europe

1.3.3&nbsp;&nbsp;&nbsp; Asia Pacific

1.3.4&nbsp;&nbsp;&nbsp; Latin America

1.3.5&nbsp;&nbsp;&nbsp; MEA

1.4&nbsp;&nbsp;&nbsp; Forecast calculations

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data sources

1.6.1&nbsp;&nbsp;&nbsp; Primary

1.6.2&nbsp;&nbsp;&nbsp; Secondary

1.6.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.6.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Point of care molecular diagnostics industry 3600&nbsp;synopsis, 2018 - 2032

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Technology trends

2.1.3&nbsp;&nbsp;&nbsp; Application trends

2.1.4&nbsp;&nbsp;&nbsp; End-use trends

2.1.5&nbsp;&nbsp;&nbsp; Regional trends

Chapter 3&nbsp;&nbsp;&nbsp;Point of Care Molecular Diagnostics Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry landscape

3.2&nbsp;&nbsp;&nbsp; Pricing analysis 2018 &ndash; 2032

3.2.1&nbsp;&nbsp;&nbsp; Pricing analysis, by region

3.2.1.1&nbsp;&nbsp;&nbsp;North America

3.2.1.2&nbsp;&nbsp;&nbsp;Europe

3.2.1.3&nbsp;&nbsp;&nbsp;Asia Pacific

3.2.1.4&nbsp;&nbsp;&nbsp;Latin America

3.2.1.5&nbsp;&nbsp;&nbsp;Middle East &amp; Africa

3.3&nbsp;&nbsp;&nbsp; Industry impact forces

3.3.1&nbsp;&nbsp;&nbsp; Growth drivers

3.3.1.1&nbsp;&nbsp;&nbsp;Increasing incidence of infectious diseases

3.3.1.2&nbsp;&nbsp;&nbsp;Increasing R&amp;D funding to reduce time required for molecular diagnostic tests

3.3.1.3&nbsp;&nbsp;&nbsp;Growing awareness about pre-disease diagnostics to control occurrence of diseases

3.3.1.4&nbsp;&nbsp;&nbsp;Technological advancements in DNA sequencing and analysis

3.3.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.3.2.1&nbsp;&nbsp;&nbsp;Long product development time

3.3.2.2&nbsp;&nbsp;&nbsp;Complex regulatory process

3.4&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4.1&nbsp;&nbsp;&nbsp; By technology

3.4.2&nbsp;&nbsp;&nbsp; By application

3.4.3&nbsp;&nbsp;&nbsp; By end-use

3.5&nbsp;&nbsp;&nbsp; COVID- 19 impact analysis

3.6&nbsp;&nbsp;&nbsp; Technology landscape

3.7&nbsp;&nbsp;&nbsp; Regulatory landscape

3.7.1&nbsp;&nbsp;&nbsp; U.S.

3.7.2&nbsp;&nbsp;&nbsp; Europe

3.8&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.9&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape

4.1&nbsp;&nbsp;&nbsp; Introduction

4.1.1&nbsp;&nbsp;&nbsp; Abbott Laboratories

4.1.2&nbsp;&nbsp;&nbsp; Bio-Rad Laboratories, Inc

4.1.3&nbsp;&nbsp;&nbsp; BioM&eacute;rieux SA

4.2&nbsp;&nbsp;&nbsp; Competitive dashboard, 2021

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis, 2021

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Strategic outlook matrix

Chapter 5&nbsp;&nbsp;&nbsp;Point of Care Molecular Diagnostics Market, By Technology

5.1&nbsp;&nbsp;&nbsp; Key technology trends

5.2&nbsp;&nbsp;&nbsp; Polymerase Chain Reaction (PCR)

5.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.3&nbsp;&nbsp;&nbsp; In situ hybridization

5.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.4&nbsp;&nbsp;&nbsp; Sequecing

5.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.5&nbsp;&nbsp;&nbsp; Isothermal amplification

5.5.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.6&nbsp;&nbsp;&nbsp; Others

5.6.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6&nbsp;&nbsp;&nbsp;Point of Care Molecular Diagnostics Market, By Application

6.1&nbsp;&nbsp;&nbsp; Key application trends

6.2&nbsp;&nbsp;&nbsp; Infectious diseases

6.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.2.2&nbsp;&nbsp;&nbsp; Flu

6.2.2.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

6.2.3&nbsp;&nbsp;&nbsp; Respiratory syncytial virus (RSV)

6.2.3.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

6.2.4&nbsp;&nbsp;&nbsp; Tuberculosis (TB)

6.2.4.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

6.2.5&nbsp;&nbsp;&nbsp; HIV

6.2.5.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

6.2.6&nbsp;&nbsp;&nbsp; Gonorrhea

6.2.6.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

6.2.7&nbsp;&nbsp;&nbsp; Chlamydia

6.2.7.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

6.2.8&nbsp;&nbsp;&nbsp; Hepatitis C

6.2.8.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

6.2.9&nbsp;&nbsp;&nbsp; Hepatitis B

6.2.9.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

6.2.10&nbsp;&nbsp;&nbsp; COVID-19

6.2.10.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.2.11&nbsp;&nbsp;&nbsp; Others

6.2.11.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.3&nbsp;&nbsp;&nbsp; Oncology

6.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.4&nbsp;&nbsp;&nbsp; Hematology

6.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.5&nbsp;&nbsp;&nbsp; Others

6.5.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7&nbsp;&nbsp;&nbsp;Point of Care Molecular Diagnostics Market, By End-use

7.1&nbsp;&nbsp;&nbsp; Key end-use trends

7.2&nbsp;&nbsp;&nbsp; Hospitals

7.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.3&nbsp;&nbsp;&nbsp; Clinics

7.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.4&nbsp;&nbsp;&nbsp; Diagnostic centers

7.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.5&nbsp;&nbsp;&nbsp; Others

7.5.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8&nbsp;&nbsp;&nbsp;Point of Care Molecular Diagnostics Market, By Region

8.1&nbsp;&nbsp;&nbsp; Key regional trends

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Italy

8.3.5&nbsp;&nbsp;&nbsp; Spain

8.3.6&nbsp;&nbsp;&nbsp; Russia

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; India

8.4.3&nbsp;&nbsp;&nbsp; Japan

8.4.4&nbsp;&nbsp;&nbsp; South Korea

8.4.5&nbsp;&nbsp;&nbsp; Malaysia

8.4.6&nbsp;&nbsp;&nbsp; Thailand

8.4.7&nbsp;&nbsp;&nbsp; Vietnam

8.4.8&nbsp;&nbsp;&nbsp; Philippines

8.4.9&nbsp;&nbsp;&nbsp; Australia

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Nigeria

8.6.3&nbsp;&nbsp;&nbsp; Egypt

8.6.4&nbsp;&nbsp;&nbsp; Morocco

8.6.5&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.6&nbsp;&nbsp;&nbsp; UAE

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Abbott Laboratories

9.2&nbsp;&nbsp;&nbsp; BioM&eacute;rieux SA

9.3&nbsp;&nbsp;&nbsp; Bio-Rad Laboratories, Inc

9.4&nbsp;&nbsp;&nbsp; Danaher Corporation

9.5&nbsp;&nbsp;&nbsp; Sysmex Corporation

9.6&nbsp;&nbsp;&nbsp; Abaxis Inc

9.7&nbsp;&nbsp;&nbsp; Mesa Biotech (Thermo Fisher Scientific)

9.8&nbsp;&nbsp;&nbsp; Roche Diagnostics

9.9&nbsp;&nbsp;&nbsp; OraSure Technologies, Inc

9.10&nbsp;&nbsp;&nbsp; VIRCELL S.L

&nbsp;&nbsp;&nbsp;

Point of Care Molecular Diagnostics Market

Get a free sample of this report

Industries

Information

Link

Global Headquarters